AXIM BIOTECHNOLOGIES, INC. reports

Company location: San Diego, CA
Fiscal year end: 31 December

AXIM BIOTECHNOLOGIES, INC. has filed 306 SEC EDGAR filings since 10 Mar 2011

Filter by type:
10-K
10-Q
8-K
SC13D

SEC filing history

Showing 51-75 of 306 matching filings.

Per page

25

Current page

3

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 23 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 13 May 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 23 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 06 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 10 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 19 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 02 Jan 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-88107

SCHEDULE 13D - JUNIPER & IVY CORP

Filing date: 23 Sep 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 20 Feb 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-54296

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filing date: 19 Sep 2022
Reporting date: 15 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13D/A File 005-88107

SCHEDULE 13D/A - CATALINA VALENCIA

Filing date: 31 Aug 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 31 Aug 2022
Reporting date: 29 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-88107

SCHEDULE 13D - GLYCODOTS, LLC

Filing date: 31 Aug 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 31 Aug 2022
Reporting date: 19 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-88107

SCHEDULE 13D - CATALINA VALENCIA

Filing date: 31 Aug 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 31 Aug 2022
Reporting date: 19 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-54296

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filing date: 29 Aug 2022
Reporting date: 29 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 26 Aug 2022
Reporting date: 22 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-54296

FORM 10-Q

Filing date: 16 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

NT 10-Q File 000-54296

AXIM BIOTECHNOLOGIES, INC. FORM NT 10-Q

Filing date: 16 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-266305

EFFECT filing

Filing date: 04 Aug 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 02 Aug 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-266305

AXIM BIOTECHNOLOGIES, INC. - FORM S1A

Filing date: 02 Aug 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 29 Jul 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1 File 333-266305

AXIM BIOTECHNOLOGIES, INC. - FORM S-1

Filing date: 25 Jul 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .